Titon (LON:TON – Get Free Report) released its earnings results on Thursday. The company reported GBX (17.41) (($0.22)) earnings per share for the quarter, Digital Look Earnings reports. Titon had a negative return on equity of 8.27% and a negative net margin of 5.06%.
Titon Stock Performance
LON:TON opened at GBX 75 ($0.93) on Friday. The company has a debt-to-equity ratio of 3.51, a quick ratio of 1.83 and a current ratio of 2.92. Titon has a fifty-two week low of GBX 60 ($0.74) and a fifty-two week high of GBX 90 ($1.11). The firm has a market cap of £8.44 million, a PE ratio of -833.33 and a beta of 0.21. The business has a 50 day moving average price of GBX 79.39 and a 200-day moving average price of GBX 72.94.
Insider Buying and Selling
In other news, insider Jeff Ward purchased 20,000 shares of the business’s stock in a transaction on Monday, October 28th. The shares were acquired at an average price of GBX 75 ($0.93) per share, with a total value of £15,000 ($18,527.67). 63.72% of the stock is owned by insiders.
Analysts Set New Price Targets
Check Out Our Latest Analysis on Titon
About Titon
Titon Holdings Plc is a leading international manufacturer and supplier of ventilation systems and window and door hardware with a reputation for quality products and high levels of customer service. Formed in 1972 we employ over 200 people, with 170 in the UK, 1 in the USA and 29 in South Korea. Titon is listed on the AIM Market on the London Stock Exchange, ticker is “TON”.
Titon has a strong presence in the UK residential ventilation market with a comprehensive range of mechanical and natural ventilation products and is also a leading supplier of window and door hardware.
Recommended Stories
- Five stocks we like better than Titon
- 3 Stocks to Consider Buying in October
- Braskem: A Green Investment in the Bioplastics Market
- Using the MarketBeat Dividend Yield Calculator
- Got 1K to Invest? These 3 Stocks Are Still Magnificent Buys
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Abbott Laboratories Will Outperform Healthcare Stocks in 2025
Receive News & Ratings for Titon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titon and related companies with MarketBeat.com's FREE daily email newsletter.